Lv1
30 积分 2023-12-11 加入
Targeting the tumour cell surface in advanced prostate cancer
12小时前
待确认
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape
2个月前
已完结
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
4个月前
已完结
From biology to the clinic — exploring liver metastasis in prostate cancer
4个月前
已完结
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
8个月前
已完结
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
8个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
10个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
11个月前
已完结
Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
11个月前
已完结
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer
1年前
已完结
The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation
1年前
已采纳
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
1年前
已采纳
皖公网安备34019202002308
